FDA Adverse Event Malfunction Summary report: N

FLO-GARD 6201 VOLUMETRIC INFUSION PUMP

MDR report key: 2051018 · Received April 12, 2011

Report

Report Number
6000001-2011-02786
Event Type
Malfunction
Date Received
April 12, 2011
Date of Event
March 21, 2011
Report Date
March 30, 2011
Manufacturer
UNKNOWN MANUFACTURING FACILITY
Product Code
FRN
PMA / PMN Number
K915522
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE SAMPLE IS NOT AVAILABLE FOR EVALUATION PER THE CUSTOMER. A FOLLOW-UP REPORT WILL BE SUBMITTED SHOULD THE DEVICE BE RECEIVED AND EVALUATED OR IF ADDITIONAL INFORMATION BECOMES AVAILABLE.

Additional Manufacturer Narrative · 1

(B)(4). ADDITIONAL INFORMATION: A SERVICE HISTORY REVIEW REVEALED NO PREVIOUS SERVICE EVENTS WERE RELATED TO THE REPORTED CONDITION. SIMILAR REPORTS HAVE BEEN RECEIVED FOR THE REPORTED PROBLEM. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTIONS ARE REQUIRED.

Description of Event or Problem · 1

THE FACILITY REPRESENTATIVE REPORTED A FLO-GARD INFUSION PUMP WHICH OVERDELIVERED DURING PATIENT USE IN THE EMERGENCY ROOM. THE DEVICE HAD BEEN PROGRAMMED TO DELIVER SALINE TO THE PATIENT AT A RATE OF 35 MILLILITERS PER HOUR. AFTER THE INFUSION WAS STARTED THE NURSE AND PARAMEDIC IN THE PATIENT'S ROOM NOTICED THAT THE DEVICE SOUNDED AS THOUGH IT HAD CHANGED TO DELIVERING AT A HIGHER RATE. OBSERVATION OF THE DEVICE DETERMINED THAT IT WAS DELIVERING AT A HIGHER RATE THAN PROGRAMMED. THE INFUSION WAS STOPPED AND THE DEVICE WAS REPROGRAMMED TO THE ORIGINAL SETTINGS. THE NURSE AND PARAMEDIC ATTEMPTED TO RUN THE INFUSION, HOWEVER THE DEVICE AGAIN BEGAN TO DELIVER AT A HIGHER RATE THAN PROGRAMMED. THERE WAS NO PATIENT INJURY OR MEDICAL INTERVENTION. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLO-GARD 6201 VOLUMETRIC INFUSION PUMP PUMP, INFUSION FRN UNKNOWN MANUFACTURING FACILITY

Patients

Seq Age Sex Outcome Treatment
1 1 YR